Early use of Hybrid Closed-loop following Total Pancreaticoduodenectomy - 02/02/25

Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Diabetes secondary to total pancreaticoduodenectomy (TP) is challenging to manage due to high glycemic variability and risk of hypoglycemia, in a frail population. We report the case of four patients with no prior diabetes who underwent TP. Three of four patients needed artificial nutritional support. Hybrid closed-loop (HCL) insulin therapy was initiated within 12 weeks of surgery. After 90 days of HCL treatment, continuous glucose measurement showed a 70.4 ± 11.8% time in range (versus 43 ± 6.5% before HCL); 0.2 ± 0.2% time below range (versus 0.6 ± 0.5% before HCL); 23.8 ± 9.1% time above range 180-250 mg/dl (versus 22.9 ± 6.1% before HCL); 4.2 ± 2.5% time above range > 250 mg/dl (versus 33.8 ± 3.9% before HCL). The glucose management indicator improved from 8.5 ± 0.6% to 6.9 ± 0.6%. There was no severe hypoglycemia or need for unplanned medical attention. Early post-operative use of HCL allowed our patients to achieve safely optimal glycemic control after TP.
Le texte complet de cet article est disponible en PDF.Key words : Closed-loop, Duodenopancreatectomy, Hybrid closed-loop, Pancreatectomy, Pancreatic diabetes, Pancreatogenic diabetes
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?